Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice

Ruta Dekeryte; Claire Hull; Kaja Plucinska; Shakil Khan; Sarah Kamli-Salino; Nimesh Mody; Nicola Morrice; Chris McLaughlin; Victor Gault; Bettina Platt; Mirela Delibegovic

doi:10.1016/j.bcp.2019.05.020

Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice

Ruta Dekeryte, Claire Hull, Kaja Plucinska, Shakil Khan, Sarah Kamli-Salino, Nimesh Mody, Nicola Morrice, Chris McLaughlin, Victor Gault, Bettina Platt, Mirela Delibegovic

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

9 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Biochemical Pharmacology
Vol/bind	166
Sider (fra-til)	222-230
ISSN	0006-2952
DOI	https://doi.org/10.1016/j.bcp.2019.05.020
Status	Udgivet - 2019
Udgivet eksternt	Ja

Adgang til dokumentet

10.1016/j.bcp.2019.05.020

Citationsformater

@article{6050babf394e4dcdab5c1a38e0ed2afa,

title = "Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice",

keywords = "BACE1, Type 2 diabetes, DPP4, Liraglutide, Insulin resistance",

author = "Ruta Dekeryte and Claire Hull and Kaja Plucinska and Shakil Khan and Sarah Kamli-Salino and Nimesh Mody and Nicola Morrice and Chris McLaughlin and Victor Gault and Bettina Platt and Mirela Delibegovic",

year = "2019",

doi = "10.1016/j.bcp.2019.05.020",

language = "English",

volume = "166",

pages = "222--230",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier",

}

TY - JOUR

T1 - Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice

AU - Dekeryte, Ruta

AU - Hull, Claire

AU - Plucinska, Kaja

AU - Khan, Shakil

AU - Kamli-Salino, Sarah

AU - Mody, Nimesh

AU - Morrice, Nicola

AU - McLaughlin, Chris

AU - Gault, Victor

AU - Platt, Bettina

AU - Delibegovic, Mirela

PY - 2019

Y1 - 2019

KW - BACE1

KW - Type 2 diabetes

KW - DPP4

KW - Liraglutide

KW - Insulin resistance

U2 - 10.1016/j.bcp.2019.05.020

DO - 10.1016/j.bcp.2019.05.020

M3 - Journal article

C2 - 31103416

SN - 0006-2952

VL - 166

SP - 222

EP - 230

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

ER -